Yeomans Consulting Group Inc. Cuts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Yeomans Consulting Group Inc. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 630 shares of the healthcare conglomerate’s stock after selling 34 shares during the quarter. Yeomans Consulting Group Inc.’s holdings in UnitedHealth Group were worth $319,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. APG Asset Management US Inc. grew its holdings in UnitedHealth Group by 5.3% in the second quarter. APG Asset Management US Inc. now owns 351,983 shares of the healthcare conglomerate’s stock worth $174,108,000 after purchasing an additional 17,747 shares during the last quarter. Ameriprise Financial Inc. grew its stake in UnitedHealth Group by 0.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after buying an additional 21,149 shares during the last quarter. Employees Retirement System of Texas raised its stake in UnitedHealth Group by 9.2% in the second quarter. Employees Retirement System of Texas now owns 198,670 shares of the healthcare conglomerate’s stock valued at $101,175,000 after buying an additional 16,800 shares during the last quarter. Eminence Capital LP purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $26,657,000. Finally, Drucker Wealth 3.0 LLC acquired a new stake in UnitedHealth Group in the 2nd quarter worth approximately $1,062,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.8 %

Shares of NYSE UNH opened at $528.94 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s 50-day simple moving average is $543.52 and its 200-day simple moving average is $563.78. The firm has a market cap of $486.77 billion, a price-to-earnings ratio of 34.12, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.59%. UnitedHealth Group’s payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNH. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. UBS Group cut their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.